Product NDC: | 52584-482 |
Proprietary Name: | Xylocaine |
Non Proprietary Name: | Lidocaine Hydrochloride and Epinephrine |
Active Ingredient(s): | .01; 10 mg/mL; mg/mL & nbsp; Lidocaine Hydrochloride and Epinephrine |
Administration Route(s): | INFILTRATION; PERINEURAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-482 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA006488 |
Marketing Category: | NDA |
Start Marketing Date: | 20110912 |
Package NDC: | 52584-482-27 |
Package Description: | 1 VIAL in 1 BAG (52584-482-27) > 20 mL in 1 VIAL |
NDC Code | 52584-482-27 |
Proprietary Name | Xylocaine |
Package Description | 1 VIAL in 1 BAG (52584-482-27) > 20 mL in 1 VIAL |
Product NDC | 52584-482 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INFILTRATION; PERINEURAL |
Start Marketing Date | 20110912 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
Strength Number | .01; 10 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |